View Document Preview and Link Document Date: 2014-07-14 17:40:36 Open Document File Size: 249,78 KB Share Result on Facebook
City Horsham / Schaffhausen / / Company Treatment Criteria [*Sections or subsections omitted from the full prescribing information are not listed] Laboratory / Cilag AG / Janssen Biotech Inc. / International Working Group / / Country Switzerland / / Currency pence / / Event FDA Phase / / IndustryTerm healthcare / resuscitation equipment / infusion solution / / MedicalCondition Anaphylactic reaction / allergic reaction / Efficacy Endpoint Durable tumor / HIV / chest pain / nausea / skin rash / anaphylaxis / Severe hypersensitivity / another hematologic disease / Concurrent Active Severe Infections / diarrhea / Hypersensitivity / severe infections / end stage renal disease / pruritus / infections / back pain / respiratory tract infection / wheezing / upper respiratory tract infection / Hypotension / light-headedness / Abdominal pain / tumor / hematological and non-hematological malignancies / disease / flushing / arthralgia / CONTRAINDICATIONS Severe hypersensitivity / Carcinogenesis / acute inflammation / malignant lymphoma / durable tumor / rash maculopapular / rash popular and rash pruritic / erythema / itching / fever / vomiting / pain / allergic reactions / chest tightness / infection / dizziness / inflammation / rash / multicentric Castleman’s disease / / MedicalTreatment oral contraceptives / birth control / Retreatment / Vaccination / Intravenous Infusion / contraception / resuscitation / Vaccinations / / Organization first SYLVANT administration / U.S. Food and Drug Administration / DOSAGE AND ADMINISTRATION / FDA / Distribution Following SYLVANT administration / / Person Edema / / / Position pharmacist / General / Thrombocytopenia General / / Product acetaminophen / cyclosporine / Dextrose / Sterile Water for Injection / theophylline / lovastatin / SYLVANT solution / SYLVANT / / ProvinceOrState Pennsylvania / / Technology antibodies / Pharmacokinetics / Pharmacodynamics / / URL www.fda.gov / www.Sylvant.com / / SocialTag 
HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use SYLVANT ™ safely and effectively. See full prescribing information for SYLVANT. SYLVANT (siltuximab) for Injection